(310) 979-3434

Address :

11633 San Vincente Blvd.
Suite #107
Los Angeles, CA 90049

Tel : (310) 979-3434
Fax : (310) 907-5193
     
email : info@drrashel.com

Literature on Bioidentical

Scientific Literature

Authors:

Birrell SN, Butler LM, Harris JM, Buchanan G, Tilley WD

Title:

Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer.

Citation:

FASEB J 2007 Apr 5; Epub ahead of print

Pub. Date:

4/5/2007

Authors:

Ribot C, Tremollieres F

Title:

[Hormone replacement therapy in postmenopausal women: all the treatments are not the same.] TRANSLATION ATTACHED

Citation:

Gynecol Obstet Fertil 2007 Mar 26; [Epub ahead of print]

Pub. Date:

3/26/2007

Authors:

Xu et al.

Title:

Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.

Citation:

Maturitas 2006 Sept 6 [Epub ahead of print]

Pub. Date:

9/6/2006

Authors:

Hyder SM

Title:

Sex-steroid regulation of vascular endothelial growth factor in breast cancer.

Citation:

Endocr Relat Cancer. 2006 Sep;13(3):667-87.

Pub. Date:

9/1/2006

Authors:

Wood CE, Register TC, Lees CJ, Chen H, Kimrey S, Mark Cline J

Title:

Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.

Citation:

Breast Cancer Res Treat 2006 Jul 14; [Epub ahead of print]

Pub. Date:

7/14/2006

Authors:

Moskowitz D

Title:

A Comprehensive Review of the Safety and Efficacy of Bioidentical Hormones for the Management of Menopause and Related Health Risks.

Citation:

Alternative Medicine Review 2006;11(3):208-223

Pub. Date:

1/1/2006

Authors:

Cirpan, Terek, Ozsener, Kanit, Pogun, Zekioglu, Yucebilgin

Title:

Proliferative effects of different hormone regimes on mammary glands in ovariectomized rats

Citation:

Eur J Gynecol Oncol. 2006 27(3):256-261.

Pub. Date:

1/1/2006

Authors:

Campagnoli C, Abba C, Ambroggio S, Peris C.

Title:

Pregnancy, progesterone and progestins in relation to breast cancer risk.

Citation:

J Steroid Biochem Mol Biol. 2005 Oct 21; [Epub ahead of print]

Pub. Date:

10/21/2005

Authors:

Mirkin S, Wong BC, Archer DF.,

Title:

Effect of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.

Citation:

Fertil Steril. 2005 Aug;84(2):485-91.

Pub. Date:

8/1/2005

Authors:

Menendez JA, Oza BP, Colomer R, Lupu R.

Title:

The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.

Citation:

Int J Oncol. 2005 Jun;26(6):1507-15.

Pub. Date:

6/1/2005

Authors:

Proietti C, Salatino M, Rosemblit C, Carnevale R, Pecci A, Kornblihtt AR, Molinolo AA, Frahm I, Charreau EH, Schillaci R, Elizalde PV.

Title:

Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.

Citation:

Mol Cell Biol. 2005 Jun;25(12):4826-40.

Pub. Date:

6/1/2005

Authors:

Campagnoli C, Clavel-Chapelon F, Kaaks R, Peris C, Berrion F.

Title:

Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

Citation:

J Steroid Biochem Mol Biol. 2005 May 20; [Epub ahead of print]

Pub. Date:

5/20/2005

Authors:

Jordan VC.

Title:

Medroxyprogesterone acetate and metastases: of mice and (wo)men.

Citation:

J Natl Cancer Inst. 2005 May 4;97(9):619-21.

Pub. Date:

5/4/2005

Authors:

Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F.

Title:

"Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. "

Citation:

Int J Cancer. 2005 Apr 10;114(3):448-54

Pub. Date:

4/10/2005

Authors:

Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N.

Title:

KEEPS: The Kronos Early Estrogen Prevention Study.

Citation:

Climacteric. 2005 Mar;8(1):3-12.

Pub. Date:

3/1/2005

Authors:

Colditz GA,

Title:

Estrogen, estrogen plus progestin therapy, and risk of breast cancer.

Citation:

Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):909s-17s

Pub. Date:

1/15/2005

Authors:

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

Title:

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Citation:

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

Pub. Date:

12/15/2004

Authors:

Moskowitz D.

Title:

Comment on Bioidentical hormone therapy: a review". (and author reply)"

Citation:

Menopause. 2004 Nov-Dec;11(6 Pt 1):639; author reply 639-41.

Pub. Date:

11/1/2004

Authors:

Druckmann, R

Title:

Progestins and their effects on the breast.

Citation:

Maturitas. 2003 Dec 10;46 Suppl 1:S59-69

Pub. Date:

12/10/2003

Authors:

Franke, HR, Vermes, I

Title:

Differential effects of progestogens on breast cancer cell lines.

Citation:

Maturitas. 2003 Dec 10;46 Suppl 1:S55-8

Pub. Date:

12/10/2003

Authors:

Mueck, AO, Seeger, H, Wallwiener, D

Title:

Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.

Citation:

Climacteric. 2003 Sep;6(3):221-7

Pub. Date:

9/1/2003

Authors:

Suparto IH, Williams JK, Cline JM, Anothony MS, Fox JL.

Title:

Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.

Citation:

Am J Obstet Gynecol. 2003 May;188(5):1132-40.

Pub. Date:

5/1/2003

Authors:

Seeger, H, Wallwiener, D, Mueck, AO

Title:

The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.

Citation:

Horm Metab Res. 2003 Feb;35(2):76-80

Pub. Date:

2/1/2003

Authors:

Greendale, GA, Reboussin, BA, Slone, S, Wasilauskas, C, Pike, MC, Ursin, G

Title:

Postmenopausal hormone therapy and change in mammographic density.

Citation:

J Natl Cancer Inst. 2003 Jan 1;95(1):30-7

Pub. Date:

1/1/2003

Authors:

de Lignieres, B, Vathaire, F, Fournier, S, Urbinelli, R, Allaert, F, Le, M, Kuttenn, F

Title:

Combined hormone replacement therapy and risk of breast cancer in a french cohort study of 3175 women.

Citation:

Climacteric 2002;5:332-40

Pub. Date:

1/1/2002

Authors:

McCarty, MF

Title:

Androgenic progestins amplify the breast cancer risk associated with hormone replacement therapy by

boosting IGF-I activity.

Citation:

Med Hypotheses. 2001 Feb;56(2):213-6

Pub. Date:

2/1/2001

Authors:

Greendale, GA, Reboussin, BA, Sie, A, Singh, HR, Olson, LK, Gatewood, O, Bassett, LW, Wasilauskas,

C, Bush, T, Barrett-Connor, E

Title:

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal  Estrogen/Progestin Interventions (PEPI) Investigators.

Citation:

Ann Intern Med. 1999 Feb 16;130(4 Pt 1):262-9

Pub. Date:

2/16/1999

Authors:

Foidart, JM, Colin, C, Denoo, X, Desreux, J, Beliard, A, Fournier, S, de Lignieres, B

Title:

Estradiol and progesterone regulate the proliferation of human breast epithelial cells.

Citation:

Fertil Steril. 1998 May;69(5):963-9

Pub. Date:

5/1/1998

Authors:

Espeland, M, Marcovina, S, Miller, V, Wood, P, Wasilauskas, C, Sherwin, R, Schrott, H, Bush, T

Title:

Effect of postmeopausal hormone therapy on lipoprotein (a) concentration.

Citation:

Circulation 1998;97:979-86

Pub. Date:

3/14/1998

Authors:

Staffa JA, Newschaffer CJ, Jones JK, Miller V.

Title:

Progestins and breast cancer: an epidemiologic review

Citation:

Fertil Steril. 1992 Mar;57(3):473-91. Review.

Pub. Date:

3/1/1992

Authors:

Birrell SN, Butler LM, Harris JM, Buchanan G, Tilley WD

Title:

Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer.

Citation:

FASEB J 2007 Apr 5; Epub ahead of print

Pub. Date:

4/5/2007

Authors:

Conner, P

Title:

"Breast response to menopausal hormone therapy--aspects on proliferation, apoptosis and mammographic density. "

Citation:

"Ann Med. 2007;39(1):28-41. Review. "

Pub. Date:

4/1/2007

Authors:

Ribot C, Tremollieres F

Title:

[Hormone replacement therapy in postmenopausal women: all the treatments are not the same.] TRANSLATION ATTACHED

Citation:

Gynecol Obstet Fertil 2007 Mar 26; [Epub ahead of print]

Pub. Date:

3/26/2007

Authors:

Fournier A, Berrino F, Clavel-Chapelon F.

Title:

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.

Citation:

Breast Cancer Res Treat. 2007 Feb 27; [Epub ahead of print]

Pub. Date:

2/27/2007

Authors:

Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Levesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group.

Title:

Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.

Citation:

Circulation. 2007 Feb 20;115(7):840-5.

Pub. Date:

2/20/2007

Authors:

Grady D, Vittinghoff E, Lin F, Hanes V, Ensrud K, Habel LA, Wallace R, Macer J, Cummings SR, Shepherd J.

Title:

Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women.

Citation:

Menopause. 2007 Jan 11; [Epub ahead of print]

Pub. Date:

1/11/2007

Authors:

Moe RE, Anderson BO.

Title:

"Androgens and androgen receptors: A clinically neglected sector in breast cancer biology. "

Citation:

"J Surg Oncol. 2006 Dec 27; [Epub ahead of print] "

Pub. Date:

12/27/2006

Authors:

Ravdin PM, Cronin KA, Howlander N, Chlebowski RT, Berry DA

Title:

A sharp decrease in breast cancer incidence in the United States in 2003.

Citation:

San Antonio Breast Cancer Symposium Abstract #5, 12/14/2006 General Session

Pub. Date:

12/14/2006

Authors:

Lyytinen H, Pukkala E, Ylikorkala O

Title:

Breast cancer risk in postmenopausal women using estrogen-only therapy.

Citation:

Obstet Gynecol 2006 Dec;108(6):1354-60

Pub. Date:

12/1/2006

Authors:

Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ.

Title:

Recent declines in HT utilization and breast cancer incidence.

Citation:

J Clin Oncol. 2006 Nov 20;24(33):e49-50.

Pub. Date:

11/20/2006

Authors:

Hyder SM

Title:

Sex-steroid regulation of vascular endothelial growth factor in breast cancer.

Citation:

Endocr Relat Cancer. 2006 Sep;13(3):667-87.

Pub. Date:

9/1/2006

Authors:

Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA

Title:

Combined Estrogen and Testosterone Use and Risk of Breast Cancer in Postmenopausal Women

Citation:

Arch Int Med 2006;166(14):1483-1489.

Pub. Date:

7/24/2006

Authors:

Wood CE, Register TC, Lees CJ, Chen H, Kimrey S, Mark Cline J

Title:

Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.

Citation:

Breast Cancer Res Treat 2006 Jul 14; [Epub ahead of print]

Pub. Date:

7/14/2006

Authors:

Hsia J, Criqui MH, Herrington DM, Manson JE, Wu L, Heckbert SR, Allison M, McDermott MM, Robinson J, Masaki K

Title:

Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative.

Citation:

Am Heart J 152(1):170

Pub. Date:

7/1/2006

Authors:

Benakanakere I, Besch-Willifors, SChnell J, Brandt S, Ellersieck MR, molinolo A, Hyder SM

Title:

Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.

Citation:

Clin Cancer Res 2006 Jul1;12(13):4062-71

Pub. Date:

7/1/2006

tbody>

Authors:

Zegura B et al.

Title:

The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.

Citation:

Menopause 2006 Jul-Aug;13(4):643-50.

Pub. Date:

7/1/2006

Authors:

Anderson et al.

Title:

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin

Citation:

Maturitas 2006

Pub. Date:

7/1/2006

Authors:

Li CI, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS, Press MF, McDonald JA, Ursin G, Burkman RT, Deapen D, Spirtas R.

Title:

Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer.

Citation:

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):946-54.

Pub. Date:

5/1/2006

Authors:

Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED, Lane DS, Hubbell FA, Assaf AR, Sarto GE, Schenken RS, Yasmeen S, Lessin L, Chlebowski RT; WHI Investigators.

Title:

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

Citation:

JAMA. 2006 Apr 12;295(14):1647-57.

Pub. Date:

4/12/2006

Authors:

Garcia-Perez MA, Moreno-Mercer J, Tarin JJ, Cano A

Title:

Similar efficacy of low and standard doses of transdermal estradiol in controlling bone turnover in postmenopausal women.

Citation:

Gynecol Endocrinol 2006 Apr;22(4):179-84.

Pub. Date:

4/1/2006

Authors:

Moskowitz D

Title:

A Comprehensive Review of the Safety and Efficacy of Bioidentical Hormones for the Management of Menopause and Related Health Risks.

Citation:

Alternative Medicine Review 2006;11(3):208-223

Pub. Date:

1/1/2006

Authors:

Kaaks et al.

Title:

Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.

Citation:

Endocr Relat Cancer 12(4):1071-82

Pub. Date:

12/1/2005

Authors:

Ghatge RP, Jacobsen BM, Schittone SA, Horwitz KB

Title:

The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells.

Citation:

Breast Cancer Res2005;7(6):R1036-50. Epub 2005 Nov 2

Pub. Date:

11/2/2005

Authors:

Campagnoli C, Abba C, Ambroggio S, Peris C.

Title:

Pregnancy, progesterone and progestins in relation to breast cancer risk.

Citation:

J Steroid Biochem Mol Biol. 2005 Oct 21; [Epub ahead of print]

Pub. Date:

10/21/2005

Authors:

Mirkin S, Wong BC, Archer DF.,

Title:

Effect of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.

Citation:

Fertil Steril. 2005 Aug;84(2):485-91.

Pub. Date:

8/1/2005

Authors:

Ropponen A, Aittomaki K, Vihma V, Tikkanen MJ, Ylikorkala O.

Title:

Effects of oral and transdermal estradiol administration on levels of sex hormone-binding globulin in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy.

Citation:

J Clin Endocrinol Metab. 2005 Jun;90(6):3431-4. Epub 2005 Mar 22.

Pub. Date:

6/1/2005

Authors:

Campagnoli C, Clavel-Chapelon F, Kaaks R, Peris C, Berrion F.

Title:

Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.

Citation:

J Steroid Biochem Mol Biol. 2005 May 20; [Epub ahead of print]

Pub. Date:

5/20/2005

Authors:

Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F., ,

Title:

"Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort."

Citation:

Int J Cancer. 2005 Apr 10;114(3):448-54

Pub. Date:

4/10/2005

Authors:

Matthews KA, Owens JF, Salomon K, Harris KF, Berga SL

Title:

Influence of hormone therapy on the cardiovascular responses to stress of postmenopausal women.

Citation:

Biol Psychol 2005 Apr;69(1):39-56. Epub 2005 Jan 4.

Pub. Date:

4/1/2005

Authors:

Dias AR, Melo RN, Gebara OC, D'Amico EA, Nussbacher A, Halbe HW, Pinotti JA

Title:

Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.

Citation:

Climacteric 2005 Mar;8(1):63-70

Pub. Date:

3/1/2005

Authors:

Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N.

Title:

KEEPS: The Kronos Early Estrogen Prevention Study.

Citation:

Climacteric. 2005 Mar;8(1):3-12.

Pub. Date:

3/1/2005

Authors:

Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Vacca F, Genazzani AR.

Title:

Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.

Citation:

Maturitas. 2005 Feb 14;50(2):91-7.

Pub. Date:

2/14/2005

Authors:

Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, Larson JC,

Title:

"Effect of estrogen therapy on gallbladder disease. "

Citation:

JAMA. 2005 Jan 19;293(3):330-9

Pub. Date:

1/19/2005

Authors:

Ropponen A, Aittomaki K, Tikkanen MJ, Ylikorkala O

Title:

Levels of serum C-reactive protein during oral and transdermal estradiol in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy.

Citation:

J Clin Endocrinol Metab 2005 Jan;90(1):142-6. Epub 2004 Nov 2

Pub. Date:

1/1/2005

Authors:

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

Title:

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Citation:

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

Pub. Date:

12/15/2004

Authors:

Decensi A, Bonanni B, Baglietto L, et al.

Title:

A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.

Citation:

Clin Cancer Res 2004 Jul 1;10(13):4389-97

Pub. Date:

7/1/2004

Authors:

Prifti S, Lelle I, Strowitzki T, Rabe T.

Title:

Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells.

Citation:

Gynecol Endocrinol. 2004 Jul;19(1):18-21.

Pub. Date:

7/1/2004

Authors:

Hermsmeyer RK, Mishra RG, Pavcnik D, Uchida B, Axhelm MK, Stanczyk FZ, Burry KA, Illingworth DR, Juan C, Nordt FJ

Title:

Prevention of coronary hyperreactivity in preatherogenic menopausal rhesus monkeys by transdermal progesterone.

Citation:

Ateriosacler thromb Vasc Biol 2004 May;24(5):955-61.

Pub. Date:

5/1/2004

Authors:

Nelson, H

Title:

Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.

Citation:

JAMA 2004;291:1610-20

Pub. Date:

4/7/2004

Authors:

Minkin, MJ

Title:

Considerations in the choice of oral vs. transdermal hormone therapy: a review.

Citation:

J Reprod Med. 2004 Apr;49(4):311-20

Pub. Date:

4/1/2004

Authors:

Stahlberg, C, Pedersen, A, Lynge, E, Anderson, Z, Keiding, N, Hundrup, Y, Obel, E, Ottesen, B

Title:

Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.

Citation:

Int. J. Cancer:109,721-727 (2004)

Pub. Date:

1/1/2004

Authors:

Rosano G, Vitale C, Silvestri A, Fini M

Title:

Metabolic and vascular effect of progestins in post-menopausal women ;Implications for cardioprotection

Citation:

Maturitas 46 Suppl 1:17-29.

Pub. Date:

12/10/2003

Authors:

Schindler A, Campagnoli C, Drukmann R, Huber J, Pasqualini J, Schweppe KW, Thijssen JH

Title:

Classification and pharmacology of progestins

Citation:

Maturitas 46 Suppl 1:7-16

Pub. Date:

12/10/2003

Authors:

Schindler A

Title:

Differential effects of progestins: European Progestin Club

Citation:

Maturitas 2003;46 Suppl 1:s3-s5

Pub. Date:

12/10/2003

Authors:

Campagnoli, C, Abba, C, Ambroggio, S, Peris, C

Title:

Differential effects of progestins on the circulating IGF-I system.

Citation:

Maturitas. 2003 Dec 10;46 Suppl 1:S39-44

Pub. Date:

12/10/2003

Authors:

Nugent, AG, Leung, KC, Sullivan, D, Reutens, AT, Ho, KK

Title:

Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.

Citation:

Clin Endocrinol (Oxf). 2003 Dec;59(6):690-8

Pub. Date:

12/1/2003

Authors:

Stanczyk, FZ

Title:

All progestins are not created equal.

Citation:

Steroids. 2003 Nov;68(10-13):879-90

Pub. Date:

11/1/2003

Authors:

Mueck, AO, Seeger, H, Wallwiener, D

Title:

Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.

Citation:

Climacteric. 2003 Sep;6(3):221-7

Pub. Date:

9/1/2003

Authors:

Million Women Study Collaborators (Beral)

Title:

Breast Cancer and Hormone Replacement Therapy in the Million Women Study.

Citation:

Lancet 2003; 362:419-27

Pub. Date:

8/9/2003

Authors:

Li, CI, Malone, KE, Porter, PL, Weiss, NS, Tang, MT, Cushing-Haugen, KL, Daling, JR

Title:

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.

Citation:

"JAMA. 2003 Jun 25 289(24):3254-63."

Pub. Date:

6/25/2003

Authors:

Chlebowski, RT, Hendrix, SL, Langer, RD, Stefanick, ML, Gass, ML, Lane, DS, Rodabough, RJ, Gilligan, MA, Cyr, MG, Thomson, CA, Khandekar, J, Petrovitch, H, McTiernan, A, WHI Investigators

Title:

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

Citation:

"JAMA 2003;289:3243-53 289(24):3243-53."

Pub. Date:

6/25/2003

Authors:

Davison, S, Davis, SR, Hunskaar, S, Skolbekken, JA

Title:

New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy.

Citation:

J Clin Endocrinol Metab 2003;88:2470-8

Pub. Date:

6/1/2003

Authors:

Wassertheil-Smoller, S, Hendrix, SL, Limacher, M, Heiss, G, Kooperberg, C, Baird, A, Kotchen, T, Curb, JD, Black, HR, Rossouw, JE, Aragaki, AK, Safford, M, Stein, E, Laowattana, S, Mysiw, WJ, WHI Investigators

Title:

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. "

Citation:

JAMA. 2003 May 28 289(20):2717-9."

Pub. Date:

5/28/2003

Authors:

Yu H, Shu XO, Shi R, Dai Q, Jin F, Gao YT, Li BD, Zheng W

Title:

Plasma sex steroid hormones and breast cancer risk in Chinese women.

Citation:

Int J Cancer 105(1):92-7

Pub. Date:

5/20/2003

Authors:

Lippert, TH, Seeger, H, Mueck, AO

Title:

Are pharmacological considerations of relevance in hormone replacement therapy for prevention of chronic disease?

Citation:

J Obstet Gynaecol. 2003 May;23(3):263-6

Pub. Date:

5/1/2003

Authors:

Vongpatanasin W, Tuncel M, Wang Z, Arbique D, Mehrad B, Jialal I

Title:

Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women

Citation:

J Am Coll Cardiol 2003;41;1358-1363

Pub. Date:

04/00/2003

Authors:

Kraemer GR, Kraemer RR, Ogdon BW, Kilpatrick RE, Gimpel TL, Castracane VD

Title:

Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin

Citation:

Fertility & Sterility 79(3):534-542

Pub. Date:

3/1/2003

Authors:

Singer CF, Hudelist G, Schreiber M, Kubista E.

Title:

Pharmacological modulation of IGF serum concentrations as a therapeutic approach to control the growth of malignant breast tumors.

Citation:

Drugs Today (Barc). 2003 Feb;39(2):115-25.

Pub. Date:

2/1/2003

Authors:

Greendale, GA, Reboussin, BA, Slone, S, Wasilauskas, C, Pike, MC, Ursin, G

Title:

Postmenopausal hormone therapy and change in mammographic density.

Citation:

J Natl Cancer Inst. 2003 Jan 1;95(1):30-7

Pub. Date:

1/1/2003

Authors:

Shapiro, S; Tucker G

Title:

Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the women's health initiative randomized controlled trial.

Citation:

Climacteric 2003;6:302-310

Pub. Date:

1/1/2003

Authors:

Jernstrom, H, Bendahl, P, Lidfeldt, J, Nerbrand, C, Agardh, C, Samsioe, G

Title:

A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the lund area (WHILA) study (Sweden).

Citation:

Cancer Causes Control 2003;14:673-680

Pub. Date:

1/1/2003

Authors:

Weiss, LK, Burkman, RT, Cushing-Haugen, KL, Voigt, LF, Simon, MS, Daling, JR, Norman, SA, Bernstein, L, Ursin, G, Marchbanks, PA, Strom, BL, Berlin, JA, Weber, AL, Doody, DR, Wingo, PA, McDonald, JA, Malone, KE, Folger, SG, Spirtas, R

Title:

Hormone replacement therapy regimens and breast cancer risk (1).

Citation:

Obstet Gynecol 2002;100:1148-58

Pub. Date:

12/00/2002

Authors:

Lindenfeld EA, Langer RD.

Title:

Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial.

Citation:

Obstet Gynecol. 2002 Nov;100(5 Pt 1):853-63.

Pub. Date:

11/1/2002

Authors:

de Lignieres B.

Title:

Effects of progestogens on the postmenopausal breast.

Citation:

Climacteric. 2002 Sep;5(3):229-35.

Pub. Date:

9/1/2002

Authors:

Modena MG, Bursi F, Fantini G, Cagnacci A, Carbonieri A, Fortuna A, Rossi R

Title:

Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: comparison between oral and transdermal administration of estrogen.

Citation:

Am J Med. 2002 Sep;113(4):331-4

Pub. Date:

9/1/2002

Authors:

Clarke, SC, Kelleher, J, Lloyd-Jones, H, Slack, M, Scofiel, PM

Title:

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study.

Citation:

"BJOG 2002;109:1056-62 1056-62."

Pub. Date:

09/00/2002

Authors:

Writing Group WHI, Writing Groups for the Women's Health Initiative Investigators

Title:

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Citation:

JAMA. 2002 Jul 17 288(3):321-33.

Pub. Date:

7/17/2002

Authors:

Hulley, S, Furberg, C, Barrett-Connor, E, Cauley, J, Grady, D, Haskell, W, Knopp, R, Lowery, M, Satterfield, S, Schrott, H, Vittinghoff, E, Hunninghake, D, HERS Research Group

Title:

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen / Progestin Replacement Study follow-up (HERS 2).

Citation:

JAMA. 2002;288(1):58-66.

Pub. Date:

7/3/2002

Authors:

Cummings JA, Brizendine L

Title:

Comparison of physical and emotional side effects of progesterone or medroxyprogesterone in early postmenopausal women.

Citation:

Menopause 9(4):253-63

Pub. Date:

7/1/2002

Authors:

Newcomb, PA, Titus-Ernstoff, L, Egan, KM, Trentham-Dietz, A, Baron, JA, Storer, BE, Willett, WC, Stampfer, MJ

Title:

Postmenopausal estrogen and progestin use in relation to breast cancer risk.

Citation:

"Cancer Epidemiol Biomarkers Prev. 2002 Jul 11(7):593-600."

Pub. Date:

07/00/2002

Authors:

Benshushan, A, Brzezinski, A

Title:

Hormonal manipulations and breast cancer.

Citation:

Obstet Gynecol Surv. 2002 May;57(5):314-23

Pub. Date:

5/1/2002

Authors:

Chen, C-L, Weiss, NS, Newcomb, P, Barlow, W, White, E,

Title:

Hormone replacement therapy in relation to breast cancer.

Citation:

JAMA 2002;287:734-741

Pub. Date:

2/13/2002

Authors:

de Lignieres, B, Vathaire, F, Fournier, S, Urbinelli, R, Allaert, F, Le, M, Kuttenn, F

Title:

Combined hormone replacement therapy and risk of breast cancer in a french cohort study of 3175 women.

Citation:

Climacteric 2002;5:332-40

Pub. Date:

1/1/2002

Authors:

Campagnoli C, Colombo P et al.

Title:

Positive effects on cardiovascular and breast metabolic markers or oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate

Citation:

Maturitas 2002;41:299-311

Pub. Date:

00/00/2002

Authors:

Hodis HN et al

Title:

"Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. "

Citation:

Ann Intern Med. 2001 Dec 4;135(11):939-53.

Pub. Date:

12/4/2001

Authors:

Serin IS, Ozclik B, Basbug M

Title:

Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels

Citation:

Eur J Obstet Gynecol Reprod Biol 2001;99:2222-225

Pub. Date:

12/1/2001

Authors:

Campagnoli, C, Abba, C, Ambroggio, S, Biglia, N, Ponzone, R

Title:

Breast cancer and hormone replacement therapy: putting the risk into perspective.

Citation:

Gynecol Endocrinol. 2001 Dec;15 Suppl 6:53-60

Pub. Date:

12/1/2001

Authors:

Hyder SM, Chiappetta C, Stancel GM.

Title:

Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.

Citation:

Int J Cancer. 2001 May 15;92(4):469-73.

Pub. Date:

5/15/2001

Authors:

Vehkavaara, S, Silveira, A, Hakala-Ala-Pietila, T, Virkamaki, A, Hovatta, O, Hamsten, A, Taskinen, MR, Yki-Jarvinen, H

Title:

Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.

Citation:

Thromb Haemost. 2001 Apr;85(4):619-25

Pub. Date:

4/1/2001

Authors:

Montplaisir J, Lorrain J, Denesle R, Petit D.

Title:

"Sleep in menopause: differential effects of two forms of hormone replacement therapy. "

Citation:

"Menopause. 2001 Jan-Feb;8(1):10-6. "

Pub. Date:

1/1/2001

Authors:

Godsland I

Title:

Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974 -2000

Citation:

Fertility & Sterility 2001;75:898-915

Pub. Date:

00/00/2001

Authors:

Tiras MB, Noyan V, Yildiz A, Yildirim M, Daya S

Title:

Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study.

Citation:

Hum Reprod 2000 Oct;15(10):2087-92

Pub. Date:

10/1/2000

Authors:

Sitruk-Ware, R

Title:

Progestins and cardiovascular risk markers.

Citation:

Steroids. 2000 Oct-Nov;65(10-11):651-8

Pub. Date:

10/1/2000

Authors:

Verheul, HM, Pinedo, HM

Title:

The Role of Vascular Endothelial Growth Factor (VEGF) in Tumor Angiogenesis and Early Clinical Development of VEGF-Receptor Kinase Inhibitors.

Citation:

Clin Breast Cancer. 2000 Sep;1 Suppl 1:S80-4

Pub. Date:

9/1/2000

Authors:

Herrington, DM, Reboussin, DM, Brosnihan, KB, Sharp, PC, Shumaker, SA, Snyder, TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D.

Title:

"Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. ."

Citation:

N Engl J Med. 2000 Aug 24;343(8):522-9

Pub. Date:

8/24/2000

Authors:

Shoff, SM, Newcomb, PA, Trentham-Dietz, A, Remington, PL, Mittendorf, R, Greenberg, ER, Willett, WC

Title:

Early-life physical activity and postmenopausal breast cancer: effect of body size and weight change.

Citation:

Cancer Epidemiol Biomarkers Prev. 2000;9:591-5

Pub. Date:

6/1/2000

Authors:

Ross, RK, Paganini-Hill, A, Wan, PC, Pike, MC,

Title:

Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin.

Citation:

J Natl Cancer Inst 2000;92:328-332

Pub. Date:

2/16/2000

Authors:

Schairer, C, Lubin, J, Troisi, R, Sturgeon, S, Brinton, L, Hoover, R

Title:

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.

Citation:

JAMA 2000;283:485-491

Pub. Date:

1/26/2000

Authors:

Hyder SM, Stancel GM.

Title:

Regulation of VEGF in the reproductive tract by sex-steroid hormones.

Citation:

Histol Histopathol. 2000 Jan;15(1):325-34.

Pub. Date:

1/1/2000

Authors:

Hofseth, LJ, Raafat, AM, Osuch, JR, Pathak, DR, Slomski, CA, Haslam, SZ

Title:

Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast.

Citation:

J Clin Endocrinol Metab. 1999 Dec;84(12):4559-65

Pub. Date:

12/1/1999

Authors:

Magnusson, C, Baron, JA, Correia, N, Bergstrom, R, Adami, H, Persson, I

Title:

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.

Citation:

Int J Cancer 1999;81:339-344

Pub. Date:

5/5/1999

Authors:

Stoll BA

Title:

Western nutrition and the insulin resistance syndrome: a link to breast cancer.

Citation:

Eur J CLin Nutr 53(2):83-7.

Pub. Date:

2/1/1999

Authors:

Hartl W, Wilfert HC, Heinz R

Title:

[Results of an observation study with Estrogel and Utrogestan in patients with climacteric symptoms.]

Citation:

Journal für Menopause 1999; 6 (4) (Ausgabe für Deutschland) 19-24

Pub. Date:

1/1/1999

Authors:

Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, Barrett-Connor E.

Title:

Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial.

Citation:

Obstet Gynecol. 1998 Dec;92(6):982-8.

Pub. Date:

12/1/1998

Authors:

Gerhard M, Walsh BW, Tawakol A, Haley EA, Creager SJ, Seely EW, Ganz P, Creager MA.

Title:

Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women.

Citation:

Circulation. 1998 Sep 22;98(12):1158-63.

Pub. Date:

9/22/1998

Authors:

Ridker, PM, Buring, JE, Shih, J, Matias, M, Hennekens, CH

Title:

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

Citation:

Circulation. 1998 Aug 25;98(8):731-3

Pub. Date:

8/25/1998

Authors:

Minshall, RD, Stanczyk, FZ, Miyagawa, K, Uchida, B, Azthelm, M, Novy, M, Hermsmeyer, K

Title:

Ovarian steroid protection against coronary artery hyperreactivity in rhesus monkeys.

Citation:

J Clin Endocrinol Metab. 1998 Feb;83(2):649-59

Pub. Date:

2/1/1998

Authors:

Uhler ML, Marks JW, Voig B

Title:

Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women

Citation:

J Clin Endocrinol Metab 1998;83:410-414

Pub. Date:

02/00/1998

Authors:

Bonduki CE, Lourenco DM, Baracat E

Title:

Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women

Citation:

Acta Obstet Gynecol Scand 1998;77:330-333

Pub. Date:

00/00/1998

Authors:

Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M

Title:

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.

Citation:

Arterioscler Thromb Vasc Biol 1997 Nov;17(11):3071-8

Pub. Date:

11/1/1997

Authors:

Malarkey, WB, Burleson, M, Cacioppo, JT, Poehlmann, K, Glaser, R, Kiecolt-Glaser, JK

Title:

Differential effects of estrogen and medroxyprogesterone on basal and stress-induced growth hormone release, IGF-1 levels, and cellular immunity in postmenopausal women.

Citation:

Endocrine. 1997 Oct;7(2):227-33

Pub. Date:

10/7/1997

Authors:

Grady, D, Ernster, V

Title:

Hormone Replacement Therapy And Endometrial Cancer: Are Current Regimens Safe?

Citation:

J Natl Cancer Inst. 1997 Aug 6;89(15):1088-9.

Pub. Date:

8/6/1997

Authors:

Crook D, Godsland IF, Hull J, Stevenson JC

Title:

Hormone replacement therapy with dydrogesterone and 17?-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up

Citation:

Br J Obstet Gyn 104:298.

Pub. Date:

3/1/1997

Authors:

Miyagawa, K, Rosch, J, Stanczyk, F, Hermsmeyer, K

Title:

Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm.

Citation:

Nat Med. 1997 Mar;3(3):324-7

Pub. Date:

3/1/1997

Authors:

Adams, MR, Register, TC, Golden, DL, Wagner, JD, Williams, JK

Title:

Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis.

Citation:

Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):217-21

Pub. Date:

1/1/1997

Authors:

Basbug M, Aygen E, Tayyar M

Title:

Twenty two weeks of transdermal estradiol increases sex hormone-binding globulin in surgical menopausal women

Citation:

Eur J Obstet Gynecol Reprod Bio 1997;73:149-152

Pub. Date:

00/00/1997

Authors:

Good WR, John VA, Ramirez M

Title:

Double-masked, multicenter study of an estradiol matrix transdermal delivery system (Alora) versus placebo in postmenopausal symptoms

Citation:

Clin Ther 1996;18:1093-1105

Pub. Date:

11/00/1996

Authors:

Kim, CJ, Min, YK, Ryu, WS, Kwak, JW, Ryoo, UH

Title:

Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.

Citation:

Arch Intern Med. 1996 Aug 12-26;156(15):1693-700

Pub. Date:

8/12/1996

Authors:

Lindoff C, Peterson F, Lecander I, Martinson G, Astedt B

Title:

Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease.

Citation:

Maturitas 1996 May;24(1-2):43-50

Pub. Date:

5/1/1996

Authors:

Haines, CJ, Chung, TK, Masarei, JR, Tomlinson, B, Lau, JT

Title:

An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins.

Citation:

Atherosclerosis. 1996 Jan 26;119(2):215-22

Pub. Date:

1/26/1996

Authors:

Evans SF, Davie MW

Title:

Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages.

Citation:

Clin Endocrinol (Oxf). 1996 Jan;44(1):79-84

Pub. Date:

1/1/1996

Authors:

Speroff L, Whitcomb RW, Kempfert NJ

Title:

Efficacy and local tolerance of a low-dose 7 day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms

Citation:

Obstet Gynecol 1996;88:587-591

Pub. Date:

00/00/1996

Authors:

Writing Group for the PEPI Trial

Title:

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. the postmenopausal estrogen/progestin interventions (PEPI) trial. the writing group for the PEPI trial.

Citation:

JAMA 1995;273:199-208

Pub. Date:

12/6/1995

Authors:

Bottinlione, F., Volpe, A., Esposito, G., et al

Title:

Transvaginal estriol administration in postmenopausal women: a double blind compartaive study of 2 different doses

Citation:

MAturistas 22, 227-232

Pub. Date:

1995

Authors:

Chang KJ, Lee TT, Linares-Cruz G, Fournier S, de Lignieres B.

Title:

Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo.

Citation:

Fertil Steril. 1995 Apr;63(4):785-91.

Pub. Date:

4/1/1995

Authors:

Moorjani S, Dupont A, Labrie F, De Lignieres B, Cusan L, Dupont P, Mailloux J, Lupien PJ.

Title:

Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.

Citation:

J Clin Endocrinol Metab. 1991 Aug;73(2):373-9.

Pub. Date:

8/1/1991

Authors:

Van Erpecum KJ, Van Berge Henegouwen GP, Vershoor L

Title:

Different Hepatobiliary effects of oral and transdermal estradiol in postmenopausal

Citation:

Gastroenterology 1991;100:482-488

Pub. Date:

02/00/1991

Authors:

Glass, A, Hoover, R

Title:

Rising incidence of breast cancer: relationship to stage and receptor status.

Citation:

82 J Nat Cancer Inst 1990, 693-696

Pub. Date:

4/18/1990

Authors:

Hargrove JT, Maxson WS, Wentz AC, Burnett LS

Title:

Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.

Citation:

Obstet Gynecol 73(4):606-12.

Pub. Date:

4/1/1989

Authors:

Lee NC, Rosero-Bixby L, Oberle MW, Grimaldo C, Whatley AS, Rovira EZ.

Title:

A case-control study of breast cancer and hormonal contraception in Costa Rica.

Citation:

J Natl Cancer Inst. 1987 Dec;79(6):1247-54.

Pub. Date:

12/1/1987

Authors:

Hunt K, Vessey M, McPherson K, Coleman M.

Title:

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy.

Citation:

Br J Obstet Gynaecol. 1987 Jul;94(7):620-35.

Pub. Date:

7/1/1987

Authors:

Bush, TL, Barrett-Connor, E, Cowan, LD, Criqui, MH, Wallace, RB, Suchindran, CM, Tyroloer, HA, RIfkind, BM

Title:

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

Citation:

Circulation. 1987 Jun;75(6):1102-9

Pub. Date:

6/1/1987

Authors:

Riis BJ, Thomsen K, Strom V, Christiansen C.

Title:

The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss.

Citation:

Am J Obstet Gynecol. 1987 Jan;156(1):61-5.

Pub. Date:

1/1/1987

Authors:

Barrett-Connor

Title:

Postmenopausal estrogens--current prescribing patterns of San Diego gynecologists.

Citation:

West J Med 1986 May;144(5):620-1.

Pub. Date:

5/1/1986

Authors:

Maxson WS, Hargrove JT

Title:

Bioavailability of oral micronized progesterone.

Citation:

Fertil Steril 44(5):622-6

Pub. Date:

11/1/1985

Authors:

Csech J, Gervais C.

Title:

[Utrogestan]

Citation:

Soins Gynecol Obstet Pueric Pediatr. 1985 Feb;(45):I-II. French.

Pub. Date:

10/1/1985

Authors:

Place VA, Powers M, Darley PE, Schenkel L, Good WR

Title:

A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms.

Citation:

Am J Obstet Gynecol 1985 Aug 15;152(8):1092-9

Pub. Date:

8/1/1985

Authors:

Ottosson, UB, Johansson, BG, von Schoultz, B

Title:

Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone.

Citation:

Am J Obstet Gynecol. 1985 Mar 15;151(6):746-50

Pub. Date:

3/15/1985

Authors:

Ettinger B, Genant HK, Cann CE

Title:

Long-term estrogen replacement therapy prevents bone loss and fractures.

Citation:

Ann Intern Med. 1985 Mar;102(3):319-24.

Pub. Date:

3/1/1985

Authors:

Cazenave JC et al.

Title:

Riguer ou la bonne politique pour traiter les menopause

Citation:

Medecine et Armess 12:155-168

Pub. Date:

1/1/1984

Authors:

Lane G, Siddle NC, Ryder TA, Pryse-Davies J, King RJ, Whitehead MI

Title:

Dose dependent effects of oral progesterone on the estrogenised postmenopausal endometrium.

Citation:

Br Med J (Clin Res Ed) 1983 Oct 29;287(6401):1241-5.

Pub. Date:

10/29/1983

Authors:

Csech J, Gervais C.

Title:

[Utrogestan]

Citation:

Soins Gynecol Obstet Pueric Pediatr. 1982 Sep;(16):45-6. French.

Pub. Date:

9/1/1982

Authors:

Whitehead, MI, Townsend, PT, Pryse-Davies, J, Ryder, T, Lane, G, Siddle, N, King, RJ

Title:

Actions of progestins on the morphology and biochemistry of the endometrium of postmenopausal women receiving low-dose estrogen therapy.

Citation:

Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):791-5

Pub. Date:

3/15/1982

Authors:

Morville R, Dray F, Reynier J, Barrat J

Title:

[The bioavailability of natural progesterone given by mouth. Measurement of steroid concentrations in plasma, endometrium and breast tissue]

Citation:

J Gynecol Obstet Biol reprod (Paris) 1982;11(3):355-63

Pub. Date:

1/1/1982

Authors:

Concannon PW, Spraker TR, Casey HW, Hansel W,

Title:

"Gross and histopathologic effects of medroxyprogesterone acetate and progesterone on the mammary glands of adult beagle bitches. ."

Citation:

Fertil Steril. 1981 Sep;36(3):373-87

Pub. Date:

9/1/1981

Authors:

Gambrell RD Jr, Massey FM, Castaneda TA, Ugenas AJ, Ricci CA , Wright JM

Title:

Use of the progestogen challenge test to reduce the risk of endometrial cancer

Citation:

Obstet Gynecol. 1980 Jun;55(6):732-8.

Pub. Date:

06/00/1980

Authors:

Whitehead MI, Townsend PT, Gill DK, Collins WP, Campbell S

Title:

Absorption and metabolism of oral progesterone.

Citation:

Br Med J 1980 Mar 22;280(6217):825-7.

Pub. Date:

3/22/1980

Authors:

Diamond EJ, Hollander VP

Title:

Progesterone and breast cancer

Citation:

Mt Sinai J Med 1979;46:225-235

Pub. Date:

00/00/1979

Authors:

Greenblatt RB, Stoddard LD

Title:

The estrogen--cancer controversy

Citation:

J Am Geriatrics Soc'y 1978 Jan;26(1):1-8

Pub. Date:

1/1/1978

Authors:

Greenblatt RB, Stoddard LD

Title:

The estrogen--cancer controversy

Citation:

J Am Geriatrics Soc'y 1978 Jan;26(1):1-8

Pub. Date:

1/1/1978

Authors:

Lippman M, Bolan G, Huff K.

Title:

The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.

Citation:

Cancer Res. 1976 Dec;36(12):4610-8.

Pub. Date:

12/1/1976

Authors:

Weiss NS, Szekely DR, Austin DF,

Title:

"Increasing incidence of endometrial cancer in the United States. "

Citation:

N Engl J Med. 1976 Jun 3;294(23):1259-62

Pub. Date:

6/3/1976

Authors:

Mack TM, Pike MC, Henderson BE, Pfeffer RI, Gerkins VR, Arthur M, Brown SE

Title:

Estrogens and endometrial cancer in a retirement community.

Citation:

N Engl J Med. 1976 Jun 3;294(23):1262-7

Pub. Date:

6/3/1976

Authors:

Ziel HK, Finkle WD,

Title:

Increased risk of endometrial carcinoma among users of conjugated estrogens.

Citation:

N Engl J Med. 1975 Dec 4;293(23):1167-70

Pub. Date:

12/4/1975

Authors:

Smith DC, Prentice R, Thompson DJ, Herrmann WL,

Title:

"Association of exogenous estrogen and endometrial carcinoma. "

Citation:

N Engl J Med. 1975 Dec 4;293(23):1164-7

Pub. Date:

12/4/1975

Authors:

Callantine MR, Martin PL, Bolding OT, Warner PO, Greaney MO

Title:

Micronized 17 beta-estradiol for oral estrogen therapy in menopausal women.

Citation:

Obstet Gynecol 1975 Jul;46(1):37-41

Pub. Date:

7/1/1975

Authors:

Finkel MJ, Berliner VR.

Title:

The Extrapolaiton of Experimental Findings (Animal to Man): The Dilemma of the Systemically Administered Contraceptives

Citation:

Presented at the 62nd Annual Meeting of the Internaional Academy of Pathology.

Pub. Date:

2/28/1973

Authors:

Riviere, M, Chouroulinkovi, I, Guerin, M

Title:

[Appearance of mammary tumors in the male rat subjected to combined estrogen and progesterone treatment] French article.

Citation:

C R Seances Soc Biol Fil 1961;155:2102-4

Pub. Date:

1/1/1961

Authors:

Wallach S, Henneman P

Title:

Prolonged estrogen therapy in postmenopausal women

Citation:

JAMA 171(12);1637-1642.

Pub. Date:

11/21/1959